Thomas Michael Haarlander, individually and d/b/a The Avalon Effect marketed and sold a light therapy device called the Quantum Series Wellness Pack, and made claims that the device cured and/or addressed the symptoms of Fungal Meningitis, MRSA, Lyme's disease, and other serious diseases or conditions without evidence to substantiate those claims...Avalon Effect filings.
Google used Street View cars equipped with antennae and open-source software that the company acknowledged collected network identification information from unprotected wireless networks. Google has agreed to segregate and secure the information it gathered and will destroy the information. Further, Google agreed that the data was not used, and will not be used, in any product or service...Google filings.
Beautylash MD was marketed and sold in Tennessee by Nutra-Luxe, M.D. as a product that was allegedly designed to grow longer, thicker eyelashes. The State alleged that Beautylash MD's ability to grow eyelashes arises because it may contain an analog or derivative of the drug compound prostaglandin. If Beautylash MD contains this drug compound, the State alleged that Nutra-Luxe should have obtained FDA approval prior to marketing and selling Beautylash MD in Tennessee and should have made certain disclosures to consumers. Under the terms of the settlement, Nutra-Luxe has voluntarily agreed to stop selling Beautylash MD and similar products in Tennessee without first obtaining approval from the Food and Drug Administration...Nutra-Luxe filings.
Following investigations into transactions between ElderTrust of Florida, Inc., SeniorTrust of Florida, Inc., and NHI and NHC, the Attorney General filed complaints seeking to have receivers appointed to marshal the assets and wind up the affairs of ElderTrust and SeniorTrust. The receivers alleged that NHI and NHC controlled SeniorTrust and ElderTrust and cause the Tennessee nonprofits to buy and sell nursing homes on unfair terms for the benefit of NHI and NHC...SeniorTrust/ElderTrust filings.
Tennessee has joined 29 other states in a $29 million agreement with Toyota Motor Corporation and its related North America entities. The states alleged Toyota engaged in unfair and deceptive practices when it failed to timely disclose known safety defects with accelerator pedals. Toyota will be restricted from advertising the safety of vehicles without sound engineering data to back such safety claims. The agreement also emphasizes changes in the corporate culture and corporate chain of command to enhance Toyota's responsiveness to regulatory agencies in the United States...Toyota filings.